[Form 4] LM Funding America, Inc. Insider Trading Activity

Rhea-AI Filing Summary

LM Funding America, Inc. (LMFA) reported that director Douglas I. McCree received a non-employee director stock option award on 08/27/2025 under the company’s Non-Employee Director Compensation Plan. The award grants the right to purchase 157,140 shares of common stock at an exercise price of $1.26 per share, exercisable immediately and expiring on 08/27/2035. The options vest one-half 180 days after the grant and the remaining one-half on the first anniversary of the grant date. The filing is a routine disclosure of director compensation and does not include other financial results or transactions.

Insights

Corporate Governance Expert

TL;DR Director received standard long-term option award to align interests with shareholders; vesting schedule encourages multi-year retention.

The grant of 157,140 options at $1.26 uses the company’s established Non-Employee Director Compensation Plan, indicating governance-level alignment of pay with long-term equity performance. The two-step vesting (50% at 180 days, 50% at one year) is a retention-focused schedule typical for non-employee directors. This is a standard, non-cash compensation event and appears procedural rather than an extraordinary corporate action.

Securities Analyst

TL;DR Materiality is limited; this is an equity compensation disclosure with potential dilution but no immediate cash impact.

The option award grants rights to 157,140 common shares at $1.26, exercisable through 2035. If exercised, the issuance would increase share count and dilute existing holders; however, the filing contains no indication of immediate exercise or cash proceeds. There is no accompanying financial performance data or other insider trades to suggest a change in company valuation or near-term liquidity impact.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McCree Douglas I.

(Last) (First) (Middle)

1200 PLATT STREET

SUITE 100

(Street)

TAMPA FL 33606

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LM FUNDING AMERICA, INC. [ LMFA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/27/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$1.26	08/27/2025		A		157,140		(1)	08/27/2035	Common Stock	157,140	$0	157,140	D

Explanation of Responses:

1. Option awards to purchase shares of common stock were granted under the Non-Employee Director Compensation Plan, as amended on November 18, 2022. Shares subject to the options will vest as to one-half on the 180th day after the grant date and as to one-half on the date that is the first anniversary of the grant date.

	/s/ Douglas I. McCree	08/28/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.